Search hospitals > Virginia > Charlottesville

Martha Jefferson Hospital

Claim this profile
Charlottesville, Virginia 22901
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Pancreatic Cancer
Conducts research for Breast cancer
71 reported clinical trials
3 medical researchers
Photo of Martha Jefferson Hospital in CharlottesvillePhoto of Martha Jefferson Hospital in CharlottesvillePhoto of Martha Jefferson Hospital in Charlottesville

Summary

Martha Jefferson Hospital is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Lung Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Breast cancer and other specialties. Martha Jefferson Hospital is involved with conducting 71 clinical trials across 88 conditions. There are 3 research doctors associated with this hospital, such as Joseph Newton, MD, Jefferson M. Prichard, and Andrew M. Romano.

Area of expertise

1Lung Cancer
Global Leader
Martha Jefferson Hospital has run 18 trials for Lung Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III
2Breast Cancer
Global Leader
Martha Jefferson Hospital has run 15 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
PR positive

Top PIs

Clinical Trials running at Martha Jefferson Hospital

Lung Cancer
ALK Gene Rearrangement
Colorectal Cancer
Stomach Cancer
Pancreatic Cancer
Prostate Cancer
Bladder Cancer
Esophageal Cancer
Ovarian Cancer
Breast Cancer
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Multi-Cancer Detection Test

for Cancer

The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand how MCDs may work as cancer screening tools. The goal of cancer screening is to reduce the burden of cancer by identifying cancers before they show symptoms or signs, when treatment is likely to be most effective. In this study, adults aged 45-75 without cancer will be randomly assigned to one of 3 groups: 2 separate MCD test groups or a control group. These two MCD tests will not be compared to each other but will be compared to cancers detected in the control group. This study will provide early information on how well MCD tests perform as cancer screening tools. It will also help researchers understand how patients and their doctors make decisions about their care when the MCD test result comes back as normal (negative) or abnormal (positive).
Recruiting1 award N/A1 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Martha Jefferson Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security